{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:47:27Z","timestamp":1768344447129,"version":"3.49.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary erythrocytic (PEM) is a rare autosomal dominant single gene disease. Most of the changes of gene loci can be found by whole exon gene sequencing, and the clinical symptoms and patient survival can be improved by specific site-to-site drug treatment. The other manifestations of this patient population are not remarkable. After the application of common drugs, the toxicity and side effects can be limiting. In addition to other common clinical manifestations, we found that the only unique manifestation of this patient was hypertensive crisis. Following multidisciplinary diagnosis and treatment (MDT), we decided to first control hypertension to alleviate the acute and critical patients. However, after controlling the hypertensive crisis, we unexpectedly found that the clinical symptoms of the patients had been significantly improved. Therefore, we concluded that the use of antihypertensive drugs can treat erythematous limb pain with the clinical manifestation of hypertensive crisis. Here, we describe a typical PEM disease, primary clinical features, diagnosis and treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Medical records of an 8-year-old boy with PEM were analyzed retrospectively, which included clinical characteristics, follow-up information, and SCN9A (Sodium Voltage-Gated Channel Alpha Subunit 9) gene analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The 8-year-old boy had complained of abnormal paresthesia in his feet and ankles with burning sensation and pain for 2 years. The skin of both lower legs was red and underwent ichthyosis and lichenification. Genetic analysis confirmed the existence of a SCN9A gene mutation. The symptoms were gradually improved by treating with intravenous drip and oral administration of nitroglycerin to slow his heart rhythm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Primary erythrocytic is characterized by skin ulceration, redness, elevated temperature, and severe burning pain primarily in both lower extremities. PEM can be diagnosed by genetic analysis. As this case demonstrates, treating with nitroglycerin as the drug of choice to control the hypertensive crisis significantly improved the symptoms of PEM and hypertension in this patient.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.796149","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T04:53:23Z","timestamp":1660625603000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Primary erythromelalgia mainly manifested by hypertensive crisis: A case report and literature review"],"prefix":"10.3389","volume":"10","author":[{"given":"Shuo","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanwen","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Que","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"B1","first-page":"1","article-title":"Erythromelalgia: A condition caused by microvascular arteriovenous shunting.","volume":"51","author":"Kvernebo","year":"1998","journal-title":"Vasa."},{"key":"B2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1468-3083.2008.02938.x","article-title":"Incidence of erythromelalgia: A population-based study in Olmsted County. Minnesota.","volume":"23","author":"Reed","year":"2009","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1067\/mjd.2000.109301","article-title":"Erythromelalgia: New theories and new therapies.","volume":"43","author":"Cohen","year":"2000","journal-title":"J Am Acad Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3113\/fai.2010.0264","article-title":"Erythromelalgia: A novel postoperative complication.","volume":"31","author":"Beals","year":"2010","journal-title":"Foot Ankle Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/archdermatol.2010.337","article-title":"Nonspecific capillary proliferation and vasculopathy indicate skin hypoxia in erythromelalgia.","volume":"147","author":"Kalgaard","year":"2011","journal-title":"Arch Dermatol."},{"key":"B6","first-page":"351","article-title":"Voltage-gated sodium channel Nav 1.7 and pain signal generation.","volume":"38","author":"Yang","year":"2007","journal-title":"Adv Biol Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1042\/cs20160041","article-title":"Voltage-gated sodium channels and pain-related disorders.","volume":"130","author":"Kanellopoulos","year":"2016","journal-title":"Clin Sci (Lond)."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9967","article-title":"Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7.","volume":"6","author":"Minett","year":"2015","journal-title":"Nat Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pharmthera.2013.06.003","article-title":"Delta opioid receptors in brain function and diseases.","volume":"140","author":"Chu Sin Chung","year":"2013","journal-title":"Pharmacol Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1126\/science.1156916","article-title":"The cell and molecular basis of mechanical, cold, and inflammatory pain.","volume":"321","author":"Abrahamsen","year":"2008","journal-title":"Science."},{"key":"B11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2009.11.023","article-title":"Exploring the role of nociceptor-specific sodium channels in pain transmission using Nav1.8 and Nav1.9 knockout mice.","volume":"208","author":"Leo","year":"2010","journal-title":"Behav Brain Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1124\/mol.108.047670","article-title":"ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors.","volume":"74","author":"Schmalhofer","year":"2008","journal-title":"Mol Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"9382","DOI":"10.1073\/pnas.0501549102","article-title":"Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior.","volume":"102","author":"Priest","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1542\/peds.2004-1395","article-title":"Primary Erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment.","volume":"115","author":"Nathan","year":"2005","journal-title":"Pediatrics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4103\/0256-4947.55316","article-title":"Experience with oral mexiletine in primary erythromelalgia in children.","volume":"29","author":"Iqbal","year":"2009","journal-title":"Ann Saudi Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1111\/j.1365-2230.2009.03355.x","article-title":"Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.","volume":"34","author":"Natkunarajah","year":"2009","journal-title":"Clin Exp Dermatol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.796149\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T04:53:33Z","timestamp":1660625613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.796149\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":16,"alternative-id":["10.3389\/fped.2022.796149"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.796149","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"article-number":"796149"}}